A surge of generics, biosimilars, and innovative therapies is expected in 2025, addressing conditions from cancer to chronic ...

The treatment has secured an accelerated approval pathway with the FDA based on compelling Phase ... with a rolling Biologics License Application (BLA) for RP-L102 for Fanconi Anemia, with a ...

Cancer can be a cause of low hemoglobin (anemia), and is often seen with cancer types that include leukemia, breast cancer, colon cancer, and prostate cancer. Chemotherapy and radiation treatments for ...

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license ...

A research team from the International Research Center for Medical Sciences (IRCMS) at Kumamoto University has identified a ...

A review of targeted therapies for anemia in patients with lower-risk myelodysplastic syndromes and myelofibrosis that improve transfusion independence and hemoglobin levels.

For 21 years, Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic treatment, he is the first person in New York to be cured of the disease.

July 25, 2024 — In a rigorous medical records study covering tens of thousands of patients, researchers conclude that some patients with preoperative anemia have better outcomes if they get iron ...

These games generally receive all the hype and attention, but there are plenty of other initiatives helping the NFL expand around the world, with the International Player Pathway program being a ...